Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 278

Results For "NITI"

3210 News Found

Algorithmic Biologics receives seed funding from Axilor Lab
Startup | January 11, 2022

Algorithmic Biologics receives seed funding from Axilor Lab

The company’s platform technology works like a compression algorithm for molecular testing and has applications in healthcare, pharmaceuticals, agriculture, animal husbandry, food safety, synthetic biology, and molecular biology research


Novartis and Molecular Partners report positive data for anti-viral Covid therapy
Biotech | January 10, 2022

Novartis and Molecular Partners report positive data for anti-viral Covid therapy

Topline results from the randomized EMPATHY Part A study in acute Covid-19 ambulatory patients comparing single intravenous doses of ensovibep, a DARPin antiviral therapeutic candidate vs. placebo, met the primary endpoint of viral load reduction over eight days


Arch Pharmalabs signs agreement with Orchem Technologies to use SMB platform
News | January 10, 2022

Arch Pharmalabs signs agreement with Orchem Technologies to use SMB platform

Simulated Moving Bed (SMB) technology is a highly engineered process for implementing chromatographic separation


Lilly and Entos  collaborate for therapies in multiple neurologic indications
Biotech | January 07, 2022

Lilly and Entos collaborate for therapies in multiple neurologic indications

Entos will receive an initial payment of US $50 million, which includes an equity investment by Lilly


Maharasthra Health Minister inaugurates BSV research centre at Airoli, Maharashtra
Biotech | January 07, 2022

Maharasthra Health Minister inaugurates BSV research centre at Airoli, Maharashtra

The R&D centre will endeavour to bring scientifically advanced biological, biotechnology products and novel drug delivery systems


Pfizer and BioNTech to develop first mRNA-based Shingles vaccine
Biotech | January 07, 2022

Pfizer and BioNTech to develop first mRNA-based Shingles vaccine

Product candidates will be based on BioNTech’s proprietary mRNA technology and on Pfizer’s antigen technology. Clinical trials are expected to start in the second half of 2022


Lupin launches Molnulup to treat Covid-19
News | January 07, 2022

Lupin launches Molnulup to treat Covid-19

The drug is priced at Rs 2000 for a course of 40 tablets


Merck KGaA to acquire biopharma CDMO Exelead for $780 million
Biotech | January 07, 2022

Merck KGaA to acquire biopharma CDMO Exelead for $780 million

The transaction is expected to close in the first quarter of 2022


NATHEALTH Home Care Forum launches white paper on healthcare delivery
Healthcare | January 06, 2022

NATHEALTH Home Care Forum launches white paper on healthcare delivery

10 implementation focused initiatives recommended to accelerate policy reforms, standardization of home care delivery services, and improve accessibility and affordability of care in tier II and tier III geographies


Dassault Systèmes to showcase the Virtual Twin Experience of the human body at CES 2022
Digitisation | January 04, 2022

Dassault Systèmes to showcase the Virtual Twin Experience of the human body at CES 2022

The virtual world makes it possible to visualize, test, understand and predict what cannot be seen, before a patient is treated